Takeda(TAK) - 2026 Q3 - Earnings Call Transcript

Takeda Pharmaceutical Company (NYSE:TAK) Q3 2026 Earnings call January 29, 2026 05:30 AM ET Company ParticipantsAndrew Plump - President of Research & DevelopmentChristophe Weber - CEOChristopher O'Reilly - Head of Investor RelationsJulie Kim - CEO-electMilano Furuta - CFONone - Company RepresentativeConference Call ParticipantsHidemaru Yamaguchi - AnalystHiroyuki Matsubara - AnalystMike Nedelcovych - AnalystSeiji Wakao - AnalystShinichiro Muraoka - AnalystSteve Barker - AnalystTony Ren - AnalystChristopher ...